Related Experiment Videos
Evaluation of the elderly with cancer
M Aapro1, M Extermann, L Repetto
1Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023
Nutrition education in medical schools (NEMS) project: Promoting clinical nutrition in medical schools - Perspectives from different actors.
Clinical nutrition (Edinburgh, Scotland)·2022
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A Multimodal Deep Learning Model for Preoperative Prediction of Postoperative Complications in Gastric Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026